MJH Life Sciences halka açık
[search 0]
Download the App!
show episodes
 
Artwork

1
MEDCast

MJH Life Sciences

Unsubscribe
Unsubscribe
Aylık+
 
MEDCast is a healthcare program brought to you by http://HCPLive.com that features leading medical experts who discuss a range topic within a particular condition or medical disorder.
  continue reading
 
Loading …
show series
 
Nehad Soloman, MD, FACR; Andrew Sharobeem, DO, FACR, and Sunil Patel, MD, explore the nephrologist's vital role in gout diagnosis, treatment options for gout patients with chronic kidney disease, and strategies for managing refractory gout and its associated challenges.MJH Life Sciences tarafından oluşturuldu
  continue reading
 
Nehad Soloman, MD, FACR; Andrew Sharobeem, DO, FACR, and Sunil Patel, MD, explore the nephrologist's vital role in gout diagnosis, treatment options for gout patients with chronic kidney disease, and strategies for managing refractory gout and its associated challenges.MJH Life Sciences tarafından oluşturuldu
  continue reading
 
Key opinion leaders analyze the efficacy, safety profile, and proper utilization of behind-the-counter medications such as pseudoephedrine products, exploring their mechanisms of action and potential adverse effects, while also providing strategies for pharmacists to identify contraindications, drug interactions, and appropriate dosing regimens for…
  continue reading
 
Key opinion leaders provide pharmacists with essential guidance on the appropriate dosing and administration of over-the-counter medications for common pediatric conditions, while equipping them with strategies to effectively counsel parents on symptom identification, condition management, and when to seek medical advice for children's health issue…
  continue reading
 
Key opinion leaders analyze EULAR 2024 updates on gout, chronic inflammation's systemic impact, and gout-chronic kidney disease (CKD) connections, while examining urate-lowering therapies for gout management, particularly in patients with CKD.MJH Life Sciences tarafından oluşturuldu
  continue reading
 
Plaque psoriasis experts explore recent advancements in treatment options, patient experiences, and the potential of novel oral systemic therapies to reduce the burden of this prevalent chronic condition.MJH Life Sciences tarafından oluşturuldu
  continue reading
 
Drs Isaacson, Pahwa, and Gupta discuss the management of dyskinesia and providing good ON time in Parkinson’s disease, sharing practical tips for early identification and treatment of dyskinesia, as well as their experience with current treatments.MJH Life Sciences tarafından oluşturuldu
  continue reading
 
Advanced practice providers in dermatology discuss exciting developments in the treatment landscape of plaque psoriasis. Listen to their insights into the often-challenging journey patients go on. The arrival of novel oral systemic treatment options offers opportunities to alleviate the burden of this chronic disease.…
  continue reading
 
In this episode of MEDcast, expert dermatologists delve into the practical aspects of using photodynamic therapy (PDT) for treatment of actinic keratosis. Specialists are sharing their protocols, advances in PDT delivery, tips for training clinical staff and communicating with patients.MJH Life Sciences tarafından oluşturuldu
  continue reading
 
In this episode of MEDcast, the expert panelists discuss emerging agents for treatment of schizophrenia and what we can be done to improve physician burnout. They also share approaches to creating hope for patients with schizophrenia and to improving treatment compliance.MJH Life Sciences tarafından oluşturuldu
  continue reading
 
In this episode of MEDcast, expert dermatologists discuss actinic keratosis, a premalignant skin condition. They are sharing their thoughts on the importance of early diagnosis and treatment and are delving into treatment options, in particular photodynamic treatments.MJH Life Sciences tarafından oluşturuldu
  continue reading
 
Dhiren Patel, PharmD, and Bob Busch, MD, interview Fatima Cody Stanford, MD, MPH, MPA, an obesity medicine specialist, to examine the cardiovascular (CV) impact of obesity and delve into the potential benefits of newer weight loss medications in mitigating CV risk and heart failure.MJH Life Sciences tarafından oluşturuldu
  continue reading
 
In this episode of MEDcast, the expert panelists review newest guidance for prescription of controlled substances using telemedicine, ADHD medication shortage, and approved and emerging stimulants and non-stimulants for the treatment of ADHD.MJH Life Sciences tarafından oluşturuldu
  continue reading
 
In this episode of MEDcast, expert geriatric psychiatrists explore the urgent need for effective diagnostic methods that can detect Alzheimer’s disease at an early stage. We will discuss blood-based biomarkers and other advancements that can help screen Alzheimer’s disease non-invasively and early in the disease course.…
  continue reading
 
In this MEDcast episode, Diana Isaacs, PharmD, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC, interview Dr Juan Frias to explore the mechanism of GLP-1 and GIP agonists in diabetes and weight management and examine key findings from clinical trials for the latest GLP-1/GIP dual agonist.MJH Life Sciences tarafından oluşturuldu
  continue reading
 
In this episode of MEDcast, expert geriatric psychiatrist and neurologist delve into the recent advances in the treatment of Alzheimer’s dementia. We will discuss treatments that are on the cusp of FDA approval and others that are coming down the pipeline.MJH Life Sciences tarafından oluşturuldu
  continue reading
 
In this episode of MEDcast, Dr Krieger, Dr Brandstadter, and Dr Bove discuss MS care in patients who are considering pregnancy. They highlight treatment options, monitoring recommendations during and after pregnancy, as well as other crucial considerations when caring for patients with childbearing goals.…
  continue reading
 
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP:-BC, interview Dr Robert Busch, to explore the advantages of SGLT2 inhibitors in chronic kidney disease, cardiovascular health, and their potential to improve overall patient outcomes.MJH Life Sciences tarafından oluşturuldu
  continue reading
 
Expert geriatric psychiatrists explore a frequently encountered symptom in Alzheimer’s disease, agitation. We will discuss its impact on patient’s and care giver’s quality of life, the current standard of care and the first FDA approved agent for treatment of agitation symptoms in Alzheimer’s disease.…
  continue reading
 
Loading …

Hızlı referans rehberi